GoodLuck0102
2021-08-16
好
FDA批准辉瑞公司(PFE)的蜱传脑炎疫苗
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":830578108,"tweetId":"830578108","gmtCreate":1629085602104,"gmtModify":1633687511642,"author":{"id":3585964302651088,"idStr":"3585964302651088","authorId":3585964302651088,"authorIdStr":"3585964302651088","name":"GoodLuck0102","avatar":"https://static.tigerbbs.com/344a326f3c2ab4d67b3f22a58a26f13f","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>好</p></body></html>","htmlText":"<html><head></head><body><p>好</p></body></html>","text":"好","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/830578108","repostId":2159465182,"repostType":2,"repost":{"id":"2159465182","kind":"highlight","weMediaInfo":{"introduction":"凤凰网港股","home_visible":1,"media_name":"凤凰网港股","id":"1039806269","head_image":"https://static.tigerbbs.com/b6fb647077f1ce46dc341fc35c26e817"},"pubTimestamp":1629080315,"share":"https://www.laohu8.com/m/news/2159465182?lang=&edition=full","pubTime":"2021-08-16 10:18","market":"hk","language":"zh","title":"FDA批准辉瑞公司(PFE)的蜱传脑炎疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2159465182","media":"凤凰网港股","summary":"凤凰网港股|辉瑞公司(PFE)宣布,美国食品和药物管理局(FDA)已批准蜱传脑炎疫苗(TICOVAC)用于主动免疫,以预防1岁及以上个人的TBE。TICOVAC是唯一经FDA批准的疫苗,有助于保护美国成年人和儿童在访问或生活在TBE流行地区时免受TBE病毒的侵害。在获得FDA批准后,美国疾病控制和预防中心的免疫实践咨询委员会预计将讨论关于安全和适当使用TICOVAC的建议。","content":"<html><body><p>凤凰网港股|<span>辉瑞公司(PFE)宣布,美国食品和药物管理局(</span><span>FDA</span><span>)已批准蜱传脑炎疫苗(</span><span>TICOVAC</span><span>)用于主动免疫,以预防1岁及以上个人的TBE。</span></p><p><span>TICOVAC是唯一经</span><span>FDA</span><span>批准的疫苗,</span><span>有助于保护</span><span>美国成年人和儿童</span><span>在访问或生活在TBE流行地区时免受TBE病毒的侵害。在获得FDA批准后,美国疾病控制和预防中心的免疫实践咨询委员会预计将讨论关于安全和适当使用TICOVAC的建议。</span></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA批准辉瑞公司(PFE)的蜱传脑炎疫苗</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA批准辉瑞公司(PFE)的蜱传脑炎疫苗\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039806269\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/b6fb647077f1ce46dc341fc35c26e817);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">凤凰网港股 </p>\n<p class=\"h-time\">2021-08-16 10:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>凤凰网港股|<span>辉瑞公司(PFE)宣布,美国食品和药物管理局(</span><span>FDA</span><span>)已批准蜱传脑炎疫苗(</span><span>TICOVAC</span><span>)用于主动免疫,以预防1岁及以上个人的TBE。</span></p><p><span>TICOVAC是唯一经</span><span>FDA</span><span>批准的疫苗,</span><span>有助于保护</span><span>美国成年人和儿童</span><span>在访问或生活在TBE流行地区时免受TBE病毒的侵害。在获得FDA批准后,美国疾病控制和预防中心的免疫实践咨询委员会预计将讨论关于安全和适当使用TICOVAC的建议。</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/e559c5a8390713a5a8d4b07a2667368d","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=b9938b59ba596518e88cdc30fc8e207e","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159465182","content_text":"凤凰网港股|辉瑞公司(PFE)宣布,美国食品和药物管理局(FDA)已批准蜱传脑炎疫苗(TICOVAC)用于主动免疫,以预防1岁及以上个人的TBE。TICOVAC是唯一经FDA批准的疫苗,有助于保护美国成年人和儿童在访问或生活在TBE流行地区时免受TBE病毒的侵害。在获得FDA批准后,美国疾病控制和预防中心的免疫实践咨询委员会预计将讨论关于安全和适当使用TICOVAC的建议。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1014,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/830578108"}
精彩评论